Insights

Gathering insights about FLEETCOR…

Similar companies to FLEETCOR

FLEETCOR Tech Stack

FLEETCOR uses 8 technology products and services including Blackline, OneDrive, Angular, and more. Explore FLEETCOR's tech stack below.

Blackline
Corporate Performance Management
OneDrive
File Sharing
Angular
Javascript Frameworks
Red Hat
Operating Systems
HP-UX
Operating Systems
Vercel
Platform As A Service
Kotlin
Programming Languages
CSS
Web Tools And Plugins

Media & News

Volatus Aerospace Awarded $9M Defence Contract from NATO Partner, Accelerating Growth in Uncrewed Systems
MONTRÉAL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) (“Volatus” or “the Company”), a leader in uncrewed, aerial, and defense technology solutions, is pleased to announce that it has been awarded a defence contract valued at up to CAD $9 million to supply an allied defence organization with a next-generation interim training system for Intelligence, Surveillance, and Reconnaissance (ISR) operations. The award is structured over two years, with an initial tranche of approximately $4.5 million scheduled for delivery in Q1 2026.
Dec 15, 2025 | www.globenewswire.com
Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting
- Presentations include pooled post-hoc analysis of the Phase 3 ADMIRAL and COMMODORE data on post-transplant gilteritinib resumption in relapsed or refractory FLT3m+ AML - - Findings from the Phase 3 MORPHO trial in the post-transplant maintenance setting and Phase 1/2 VICEROY trial in newly diagnosed disease highlight how treatment timing, sequencing and combination approaches may influence outcomes - TOKYO , Dec. 5, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that new data evaluating XOSPATA™ (gilteritinib) across FMS-like tyrosine kinase 3 mutation-positive (FLT3m+) acute myeloid leukemia (AML), including in relapsed or refractory (R/R), newly diagnosed and post-transplant maintenance settings, will be presented at the upcoming American Society of Hematology (ASH) Annual Meeting taking place from 6-9 December 2025 in Orlando, Fla. Through ongoing research with gilteritinib, Astellas is advancing the science of FLT3m+ AML and generating new evidence across the disease stages, to help improve long-term outcomes for people diagnosed with FLT3m+ AML.
Dec 05, 2025 | www.prnewswire.com
Volatus Aerospace Inc. (FLT:CA) Q3 2025 Earnings Call Transcript
Volatus Aerospace Inc. (FLT:CA) Q3 2025 Earnings Call Transcript
Dec 02, 2025 | seekingalpha.com
Volatus Aerospace Releases Record Third Quarter Financial Results
Largest quarterly revenue and gross profit figures in Company history Year-to-date Revenue of $26,905,671, up 32% year-over-year Quarterly Revenue of $10,605,438, up 60% year-over-year; blended gross margin of 33% Adjusted EBITDA loss of $660,661, a 52% year-over-year improvement Current cash balance strengthened to approximately $40 million after quarter-end financing Operational milestones included: new defense deployments, advancement of the Condor XL towards commercialization, and progress on Canadian manufacturing and domestic battery supply-chain initiatives MONTREAL and TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) ("Volatus" or "the Company"), a leader in aerial and defense solutions, is pleased to announce its financial results for the three and nine months ended September 30, 2025 (Q3 2025). All dollar figures are stated in Canadian dollars, unless otherwise indicated.
Dec 01, 2025 | www.globenewswire.com
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically active target doses; initial dose escalation results in 40 patients indicate a manageable safety profile across all doses assessed Company to host in-person event on Monday, December 8, 2025, at 8:00 p.m. ET CAMBRIDGE, Mass.
Nov 03, 2025 | www.globenewswire.com
Volatus Aerospace Inc. Announces Restatement of Q2 2025 Financial Results
One-time non-cash accounting adjustment related to the restructuring of the Company's balance sheet No impact on the Company's revenue, gross margin, or cash position during the period Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (FSE: ABB) (the "Company"), a Canadian leader in aerial intelligence and cargo solutions, today announced that it has restated its financial statements and management's discussion and analysis ("MD&A") for the three and six months ended June 30, 2025. The restatement reflects a non-cash, one-time accounting adjustment of $2,231,202 related to the restructuring of the Company's balance sheet, as previously announced on May 22, 2025 and April 11, 2025, and the modification and retirement of certain debt instruments.
Nov 03, 2025 | www.newsfilecorp.com
Volatus Aerospace to Attend the 2025 Maxim Growth Summit
MONTREAL, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) ( OTCQB: TAKOF) (FSE: ABB.F), a Canadian leader in aerial intelligence and unmanned aircraft systems, is excited to announce its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries.
Oct 17, 2025 | www.globenewswire.com

FLEETCOR's Email Address Formats

FLEETCOR uses at least 2 format(s):

FLEETCOR Email Formats	Example	Percentage
First.Last@fleetcor.com	John.Doe@fleetcor.com	87%
FLast@fleetcor.com	JDoe@fleetcor.com	8%
FirstLast@fleetcor.com	JohnDoe@fleetcor.com	2%
First.L@fleetcor.com	John.D@fleetcor.com	1%
First@fleetcor.com	John@fleetcor.com	1%
LF@fleetcor.com	DJ@fleetcor.com	1%
FLast@corpay.com	JDoe@corpay.com	79%
First@corpay.com	John@corpay.com	16%
First.Last@corpay.com	John.Doe@corpay.com	4%
FL@corpay.com	JD@corpay.com	1%

Frequently Asked Questions

Where is FLEETCOR's headquarters located?

FLEETCOR's main headquarters is located at 3280 Peachtree Road, Suite 2400. The company has employees across 6 continents, including North AmericaEuropeSouth America.

What is FLEETCOR's phone number?

You can contact FLEETCOR's main corporate office by phone at

+1-770-449-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is FLEETCOR's stock symbol?

FLEETCOR is a publicly traded company; the company's stock symbol is FLT.

What is FLEETCOR's official website and social media links?

FLEETCOR's official website is corpay.com and has social profiles on LinkedIn Crunchbase.

How much revenue does FLEETCOR generate?

As of December 2025, FLEETCOR's annual revenue is estimated to be $3.9B.

What is FLEETCOR's NAICS code?

FLEETCOR's NAICS code is 52 - Finance and Insurance.

How many employees does FLEETCOR have currently?

As of December 2025, FLEETCOR has approximately 5K employees across 6 continents, including North AmericaEuropeSouth America. Key team members include Ceo Brazil: A. N.Chief Executive Officer: B. B.Chief Operating Officer, Plugsurfing At Fleetcor: S. D.. Explore FLEETCOR's employee directory with LeadIQ.

What industry does FLEETCOR belong to?

FLEETCOR operates in the Financial Services industry.

What technology does FLEETCOR use?

FLEETCOR's tech stack includes BlacklineOneDriveAngularRed HatHP-UXVercelKotlinCSS.

What is FLEETCOR's email format?

FLEETCOR's email format typically follows the pattern of First.Last@fleetcor.com. Find more FLEETCOR email formats with LeadIQ.

How much funding has FLEETCOR raised to date?

As of December 2025, FLEETCOR has raised $750M in funding. The last funding round occurred on Feb 24, 2025 for $750M.

FLEETCOR

Q: What is FLEETCOR's official website and social media links?

FLEETCOR's official website is corpay.com. FLEETCOR has social profiles on LinkedIn.

Q: How many employees does FLEETCOR have currently?

FLEETCOR has approximately 5K employees.

Q: What technology does FLEETCOR use?

FLEETCOR's tech stack includes Medallia, Force.com (Salesforce), Pinterest, LinkedIn Sales Navigator, ZoomInfo.

Financial ServicesGeorgia, United States5001-10000 Employees

FLEETCOR Technologies rebranded as Corpay on March 25, 2024.

Company Overview

Headquarters: 3280 Peachtree Road, Suite 2400
Phone number: +1-770-449-****
Website: corpay.com
Stock Symbol: FLT
NAICS Code: 52 - Finance and Insurance
Employees: 5001-10000

Media & News

Funding & Financials

$750M
FLEETCOR has raised a total of $750M of funding over 8 rounds. Their latest funding round was raised on Feb 24, 2025 in the amount of $750M.
$1B$10B
FLEETCOR's revenue is estimated to be in the range of $1B$10B

Funding & Financials

$750M
FLEETCOR has raised a total of $750M of funding over 8 rounds. Their latest funding round was raised on Feb 24, 2025 in the amount of $750M.
$1B$10B
FLEETCOR's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to FLEETCOR

Chevron

Sam's Club

ARCO

bp

Wells Fargo

Bank of America

WEX

Chase

Costco

Shell

ExxonMobil

FLEETCOR Tech Stack

Media & News

Volatus Aerospace Awarded $9M Defence Contract from NATO Partner, Accelerating Growth in Uncrewed Systems

Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting

Volatus Aerospace Inc. (FLT:CA) Q3 2025 Earnings Call Transcript

Volatus Aerospace Releases Record Third Quarter Financial Results

Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting

Volatus Aerospace Inc. Announces Restatement of Q2 2025 Financial Results

Volatus Aerospace to Attend the 2025 Maxim Growth Summit

FLEETCOR's Email Address Formats

Frequently Asked Questions

Where is FLEETCOR's headquarters located?

What is FLEETCOR's phone number?

What is FLEETCOR's stock symbol?

What is FLEETCOR's official website and social media links?

How much revenue does FLEETCOR generate?

What is FLEETCOR's NAICS code?

How many employees does FLEETCOR have currently?

What industry does FLEETCOR belong to?

What technology does FLEETCOR use?

What is FLEETCOR's email format?

How much funding has FLEETCOR raised to date?

FLEETCOR

Company Overview

Media & News

Volatus Aerospace Awarded $9M Defence Contract from NATO Partner, Accelerating Growth in Uncrewed Systems

Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting

Volatus Aerospace Inc. (FLT:CA) Q3 2025 Earnings Call Transcript

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?